Replies to post #74468 on Biotech Values

[iwfal]

My point is that it had the same science @ $3 that it had @ $20 - so what changed? It was perception and "hope" and "expectations" - sometimes those expectations are under valued - sometimes way overvalued.

If you disagree with this then perhaps investing isn't your game and perhaps you should look at going into applied science rather then investing. For me it's not about the science - it's about the investment - the only reason I invest is to make our funds and myself money.

Mighty cocky for a Johnny come lately. And disingenuous in the extreme to dis someone else for being science oriented and not investment oriented when it is YOU who are touting MoA as more important than FDA action or hard data out of a ph iii.

[quantumdot]

when DNDN was waiting for their first FDA panel result it was $15 - $20 a share

They went into the advisory panel at around $5 a share and traded in the $15-25 range after it. You might want to swat up on your facts before handing out uncalled for "investing" lectures.